MMSI director awarded 3,457 RSUs in equity grant

Ward Lynne N. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Ward Lynne N. reported acquisition or exercise transactions in this Form 4 filing.

MERIT MEDICAL SYSTEMS INC director Lynne N. Ward received an equity grant. On this Form 4, she was awarded 3,457 shares of Common Stock through restricted stock units at a price of $0.00 per share as a compensation grant, not an open-market trade.

The RSUs were granted under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan and will vest on May 3, 2027, subject to her continued service to the company through that date. After this award, her directly held common stock position reported in the filing is 11,266 shares.

Insider Trade Summary

Grant/Award: 3,457 shares

Grant/Award 1 txn

Insider Ward Lynne N.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, No Par Value	3,457	$0.00	$0.00

Holdings After Transaction: Common Stock, No Par Value — 11,266 shares (Direct)

Footnotes (1)

1. F1. The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

Key Figures

RSU Grant Size: 3,457 shares Grant Price: $0.00 per share Post-transaction Holdings: 11,266 shares +1 more

4 metrics

RSU Grant Size 3,457 shares Restricted stock units granted to Lynne N. Ward

Grant Price $0.00 per share Price per share for the RSU compensation award

Post-transaction Holdings 11,266 shares Common stock directly held after the RSU grant

RSU Vesting Date May 3, 2027 Vesting date for 3,457 RSUs, subject to continued service

Key Terms

restricted stock units (RSUs), 2026 Equity Incentive Plan, vesting, continued service

4 terms

restricted stock units (RSUs) financial

"The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs)"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

2026 Equity Incentive Plan financial

"under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan"

vesting financial

"The RSUs granted to the reporting person will vest on May 3, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continued service financial

"Vesting of the RSUs is subject to continued service to the issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MMSI director Lynne N. Ward report on this Form 4?

Lynne N. Ward reported receiving a grant of 3,457 restricted stock units of MERIT MEDICAL SYSTEMS INC. The award is a compensation grant at $0.00 per share, rather than an open-market purchase or sale of existing common stock.

How many MMSI shares does Lynne N. Ward hold after this RSU grant?

After the reported transaction, Lynne N. Ward holds 11,266 shares of MERIT MEDICAL SYSTEMS INC common stock directly. This figure reflects her position following the 3,457-share restricted stock unit grant disclosed in the Form 4 filing.

When do Lynne N. Ward’s MMSI restricted stock units vest?

The 3,457 restricted stock units granted to Lynne N. Ward vest on May 3, 2027. Vesting is conditioned on her continued service to MERIT MEDICAL SYSTEMS INC through that vesting date, as described in the Form 4 footnote.

Under what plan were Lynne N. Ward’s MMSI RSUs granted?

Her 3,457 restricted stock units were granted under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. This plan provides equity-based compensation, and the RSUs vest on May 3, 2027, subject to her continued service with the company.

Was Lynne N. Ward’s MMSI Form 4 transaction a market purchase or sale?

The Form 4 reports a grant of 3,457 restricted stock units at $0.00 per share, categorized as a grant or award acquisition. It does not reflect an open-market purchase or sale of MERIT MEDICAL SYSTEMS INC common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/19/2026 - 06:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ward Lynne N.

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UTAH 84095

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	05/18/2026		A		3,457(1)	A	$0	11,266	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction involved the reporting person's receipt of a grant of 3,457 restricted stock units (RSUs) under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan. The RSUs granted to the reporting person will vest on May 3, 2027. Vesting of the RSUs is subject to continued service to the issuer through the vesting date.

	/s/ Brian G. Lloyd, Attorney-in-Fact	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)